The Impact of Nonsteroidal Anti‐Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti‐PD‐1 Therapy in Advanced Melanoma

Anti–programmed cell death protein‐1 (anti‐PD‐1) therapy has greatly improved outcomes of patients with melanoma; however, many fail to respond. Although preclinical studies suggest a potentially synergistic relationship with anti‐PD‐1 therapy and certain concurrent medications, their clinical role...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Wang, Daniel Y., McQuade, Jennifer L., Rai, Rajat R., Park, John J., Zhao, Shilin, Ye, Fei, Beckermann, Kathryn E., Rubinstein, Samuel M., Johnpulle, Romany, Long, Georgina V., Carlino, Matteo S., Menzies, Alexander M., Davies, Michael A., Johnson, Douglas B.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Brief Communications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066699/
https://ncbi.nlm.nih.gov/pubmed/32162820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0518
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados